Systemic Sclerosis Drug Market Report

Global and Region Systemic Sclerosis Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：159
  • REPORT CODE：GMM945495
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Systemic Sclerosis Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Systemic Sclerosis Drugmarket, defines the market attractiveness level of Systemic Sclerosis Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Systemic Sclerosis Drug industry, describes the types of Systemic Sclerosis Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Systemic Sclerosis Drug market and the development prospects and opportunities of Systemic Sclerosis Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Systemic Sclerosis Drug market in Chapter 13.

    By Player:

    • GlaxoSmithKline Plc

    • Corbus pharmaceuticals, Inc

    • arGentis Pharmaceuticals, LLC

    • Boehringer Ingelheim GmbH

    • Digna Biotech, SL

    • Daval International Limited

    • F Hoffmann-La Roche Ltd

    • CSL Limited

    • Fibrocell Science, Inc

    • Bristol-Myers Squibb Company

    • Allergan Plc

    • Angion Biomedica Corp

    • BioLineRx, Ltd

    • BiOrion Technologies BV

    • Bayer AG

    • GenKyoTex SA

    By Type:

    • ARG-201

    • Belimumab

    • BL-1110

    • BOT-191

    • C-82

    • Others

    By End-User:

    • Hospital

    • Clinic

    • ASCs

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Systemic Sclerosis Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Systemic Sclerosis Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Systemic Sclerosis Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Systemic Sclerosis Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Systemic Sclerosis Drug Market Analysis and Outlook to 2022

    • 7.1 Global Systemic Sclerosis Drug Consumption (2017-2022)

    • 7.2 United States Systemic Sclerosis Drug Consumption (2017-2022)

    • 7.3 Europe Systemic Sclerosis Drug Consumption (2017-2022)

    • 7.4 China Systemic Sclerosis Drug Consumption (2017-2022)

    • 7.5 Japan Systemic Sclerosis Drug Consumption (2017-2022)

    • 7.6 India Systemic Sclerosis Drug Consumption (2017-2022)

    • 7.7 South Korea Systemic Sclerosis Drug Consumption (2017-2022)

    8 Region and Country-wise Systemic Sclerosis Drug Market Analysis and Outlook to 2028

    • 8.1 Global Systemic Sclerosis Drug Consumption Forecast (2022-2028)

    • 8.2 United States Systemic Sclerosis Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Systemic Sclerosis Drug Consumption Forecast (2022-2028)

    • 8.4 China Systemic Sclerosis Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Systemic Sclerosis Drug Consumption Forecast (2022-2028)

    • 8.6 India Systemic Sclerosis Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Systemic Sclerosis Drug Consumption Forecast (2022-2028)

    9 Global Systemic Sclerosis Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Systemic Sclerosis Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global ARG-201 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Belimumab Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global BL-1110 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global BOT-191 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global C-82 Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Systemic Sclerosis Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global ASCs Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Systemic Sclerosis Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Systemic Sclerosis Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global ARG-201 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Belimumab Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global BL-1110 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global BOT-191 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global C-82 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Systemic Sclerosis Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global ASCs Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Systemic Sclerosis Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Systemic Sclerosis Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Systemic Sclerosis Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Systemic Sclerosis Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Systemic Sclerosis Drug Market Competitive Analysis

    • 14.1 GlaxoSmithKline Plc

      • 14.1.1 GlaxoSmithKline Plc Company Details

      • 14.1.2 GlaxoSmithKline Plc Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GlaxoSmithKline Plc Systemic Sclerosis Drug Product and Service

    • 14.2 Corbus pharmaceuticals, Inc

      • 14.2.1 Corbus pharmaceuticals, Inc Company Details

      • 14.2.2 Corbus pharmaceuticals, Inc Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Corbus pharmaceuticals, Inc Systemic Sclerosis Drug Product and Service

    • 14.3 arGentis Pharmaceuticals, LLC

      • 14.3.1 arGentis Pharmaceuticals, LLC Company Details

      • 14.3.2 arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Product and Service

    • 14.4 Boehringer Ingelheim GmbH

      • 14.4.1 Boehringer Ingelheim GmbH Company Details

      • 14.4.2 Boehringer Ingelheim GmbH Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Boehringer Ingelheim GmbH Systemic Sclerosis Drug Product and Service

    • 14.5 Digna Biotech, SL

      • 14.5.1 Digna Biotech, SL Company Details

      • 14.5.2 Digna Biotech, SL Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Digna Biotech, SL Systemic Sclerosis Drug Product and Service

    • 14.6 Daval International Limited

      • 14.6.1 Daval International Limited Company Details

      • 14.6.2 Daval International Limited Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Daval International Limited Systemic Sclerosis Drug Product and Service

    • 14.7 F Hoffmann-La Roche Ltd

      • 14.7.1 F Hoffmann-La Roche Ltd Company Details

      • 14.7.2 F Hoffmann-La Roche Ltd Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 F Hoffmann-La Roche Ltd Systemic Sclerosis Drug Product and Service

    • 14.8 CSL Limited

      • 14.8.1 CSL Limited Company Details

      • 14.8.2 CSL Limited Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 CSL Limited Systemic Sclerosis Drug Product and Service

    • 14.9 Fibrocell Science, Inc

      • 14.9.1 Fibrocell Science, Inc Company Details

      • 14.9.2 Fibrocell Science, Inc Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Fibrocell Science, Inc Systemic Sclerosis Drug Product and Service

    • 14.10 Bristol-Myers Squibb Company

      • 14.10.1 Bristol-Myers Squibb Company Company Details

      • 14.10.2 Bristol-Myers Squibb Company Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bristol-Myers Squibb Company Systemic Sclerosis Drug Product and Service

    • 14.11 Allergan Plc

      • 14.11.1 Allergan Plc Company Details

      • 14.11.2 Allergan Plc Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Allergan Plc Systemic Sclerosis Drug Product and Service

    • 14.12 Angion Biomedica Corp

      • 14.12.1 Angion Biomedica Corp Company Details

      • 14.12.2 Angion Biomedica Corp Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Angion Biomedica Corp Systemic Sclerosis Drug Product and Service

    • 14.13 BioLineRx, Ltd

      • 14.13.1 BioLineRx, Ltd Company Details

      • 14.13.2 BioLineRx, Ltd Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 BioLineRx, Ltd Systemic Sclerosis Drug Product and Service

    • 14.14 BiOrion Technologies BV

      • 14.14.1 BiOrion Technologies BV Company Details

      • 14.14.2 BiOrion Technologies BV Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 BiOrion Technologies BV Systemic Sclerosis Drug Product and Service

    • 14.15 Bayer AG

      • 14.15.1 Bayer AG Company Details

      • 14.15.2 Bayer AG Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Bayer AG Systemic Sclerosis Drug Product and Service

    • 14.16 GenKyoTex SA

      • 14.16.1 GenKyoTex SA Company Details

      • 14.16.2 GenKyoTex SA Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 GenKyoTex SA Systemic Sclerosis Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Systemic Sclerosis Drug

    • Figure Systemic Sclerosis Drug Picture

    • Table Global Systemic Sclerosis Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Systemic Sclerosis Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Systemic Sclerosis Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Systemic Sclerosis Drug Consumption by Country (2017-2022)

    • Figure United States Systemic Sclerosis Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Systemic Sclerosis Drug Consumption and Growth Rate (2017-2022)

    • Figure China Systemic Sclerosis Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Systemic Sclerosis Drug Consumption and Growth Rate (2017-2022)

    • Figure India Systemic Sclerosis Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Systemic Sclerosis Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Systemic Sclerosis Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Systemic Sclerosis Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Systemic Sclerosis Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Systemic Sclerosis Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Systemic Sclerosis Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Systemic Sclerosis Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Systemic Sclerosis Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ARG-201 Consumption and Growth Rate (2017-2022)

    • Figure Global Belimumab Consumption and Growth Rate (2017-2022)

    • Figure Global BL-1110 Consumption and Growth Rate (2017-2022)

    • Figure Global BOT-191 Consumption and Growth Rate (2017-2022)

    • Figure Global C-82 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global ASCs Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global ARG-201 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Belimumab Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BL-1110 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global BOT-191 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global C-82 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ASCs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Systemic Sclerosis Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Systemic Sclerosis Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Plc Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Plc Systemic Sclerosis Drug Product and Service

    • Table Corbus pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Corbus pharmaceuticals, Inc Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Corbus pharmaceuticals, Inc Systemic Sclerosis Drug Product and Service

    • Table arGentis Pharmaceuticals, LLC (Foundation Year, Company Profile and etc.)

    • Table arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table arGentis Pharmaceuticals, LLC Systemic Sclerosis Drug Product and Service

    • Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim GmbH Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim GmbH Systemic Sclerosis Drug Product and Service

    • Table Digna Biotech, SL (Foundation Year, Company Profile and etc.)

    • Table Digna Biotech, SL Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Digna Biotech, SL Systemic Sclerosis Drug Product and Service

    • Table Daval International Limited (Foundation Year, Company Profile and etc.)

    • Table Daval International Limited Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daval International Limited Systemic Sclerosis Drug Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Systemic Sclerosis Drug Product and Service

    • Table CSL Limited (Foundation Year, Company Profile and etc.)

    • Table CSL Limited Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table CSL Limited Systemic Sclerosis Drug Product and Service

    • Table Fibrocell Science, Inc (Foundation Year, Company Profile and etc.)

    • Table Fibrocell Science, Inc Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fibrocell Science, Inc Systemic Sclerosis Drug Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Systemic Sclerosis Drug Product and Service

    • Table Allergan Plc (Foundation Year, Company Profile and etc.)

    • Table Allergan Plc Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Plc Systemic Sclerosis Drug Product and Service

    • Table Angion Biomedica Corp (Foundation Year, Company Profile and etc.)

    • Table Angion Biomedica Corp Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Angion Biomedica Corp Systemic Sclerosis Drug Product and Service

    • Table BioLineRx, Ltd (Foundation Year, Company Profile and etc.)

    • Table BioLineRx, Ltd Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioLineRx, Ltd Systemic Sclerosis Drug Product and Service

    • Table BiOrion Technologies BV (Foundation Year, Company Profile and etc.)

    • Table BiOrion Technologies BV Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table BiOrion Technologies BV Systemic Sclerosis Drug Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Systemic Sclerosis Drug Product and Service

    • Table GenKyoTex SA (Foundation Year, Company Profile and etc.)

    • Table GenKyoTex SA Systemic Sclerosis Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table GenKyoTex SA Systemic Sclerosis Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US